By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GlycoMimetics, Inc. 

14915 Broschart Road
Suite 200
Rockville   Maryland  20850  U.S.A.
Phone: 301-738-1166 Fax: n/a




Company News
GlycoMimetics (GLYC) Reports Program Updates And Second Quarter 2017 Results 8/4/2017 7:06:39 AM
GlycoMimetics (GLYC) To Receive European Patent For GMI-1271 7/6/2017 9:33:45 AM
GlycoMimetics (GLYC) Appoints Boston Biomedical CEO Patricia S. Andrews To Its Board Of Directors 6/12/2017 9:36:10 AM
GlycoMimetics (GLYC) Presents Updated Data From Ongoing Phase I/II Clinical Trial Of GMI-1271 In Patients With Acute Myeloid Leukemia At ASCO 2017 Annual Meeting 6/5/2017 7:34:20 AM
GlycoMimetics (GLYC) Announces Closing Of Public Offering And Full Exercise Of Underwriters’ Option To Purchase Additional Shares 5/31/2017 6:52:25 AM
GlycoMimetics (GLYC)' GMI-1271 Receives EU Orphan Drug Designation For Acute Myeloid Leukemia 5/25/2017 8:13:58 AM
GlycoMimetics (GLYC) Announces Pricing Of Public Offering Of Common Stock 5/24/2017 7:18:07 AM
GlycoMimetics (GLYC) Announces Proposed Public Offering Of Common Stock 5/23/2017 6:16:43 AM
GlycoMimetics (GLYC) Stock Takes Off on Positive Phase II Leukemia Data, Breakthrough Tag 5/18/2017 6:13:39 AM
GlycoMimetics, Inc. (GLYC) Reports Program Updates And First Quarter 2017 Results 5/8/2017 7:32:43 AM